These data confirm that one-dose pretreatment of mice with mAb 8C6 is sufficient to provide total protection against homologous SW/GD/04 H1N1 SIV infection
These data confirm that one-dose pretreatment of mice with mAb 8C6 is sufficient to provide total protection against homologous SW/GD/04 H1N1 SIV infection. In this study, we also evaluated the ability of mAb 8C6 to protect mice from challenge with the pandemic 2009/H1N1-like virus (the heterologous strain SW/HRB/09). results indicate that mAb 8C6 safeguarded the…
Read more